Key points are not available for this paper at this time.
CD4+ TILs from melanoma can exert cytotoxic activity against autologous tumor cells (GFP+TCL#17)
Draghi et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: